Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new trial, funded by a £1.2 million National Institute of Health Research grant, will explore whether surgery is the best treatment for digital nerve injury.

None © Pixabay

The NEON study will examine the effects of surgery following digital nerve injury – damage to the small nerves which pass along the side of each finger and provide important sensation to the fingertips. The commonest nerve injury, treatment involves specialist referral and direct end to end microsurgical repair of the cut nerve ends. However, there is limited evidence, with regards to patient reported outcome measures or functional improvement, that surgical repair offers significant benefit to patients.

Abhilash Jain, Associate Professor of Plastic and Hand Surgery, at the Botnar Research Centre, NDORMS says: “Previous studies provide conflicting results and it remains unclear whether repair is the best treatment, or even needed. Our study will compare the surgical repair of the cut nerve with sutures with a surgical procedure without the use of sutures (a simple washout of the wound) and assess fingertip sensation, quality of life and the ability of the patient to return to work.”

478 adult patients with digital nerve injuries will be included in the study which will also assess neurosensory and functional recovery in both patient groups, compare complications of surgery and clinically problematic neuroma rates; and provide a basic comparison of cost effectiveness between the suture and non-suture groups.

Funding for the NEON study was granted to the the Surgical Intervention Trials Unit (SITU)  and the trial is supported by the specialist surgical societies in the UK such as the British Association of Plastic Surgery, the British Society for Surgery of the Hand and the Reconstructive Surgery Trials Network.

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19

Main Research

Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?

Professor Michael Dustin elected to the National Academy of Sciences

Awards Kennedy Main

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.